stp_bannerlogocombo twitter facebook employee contact

Synergy Therapeutic Partners (STP) is a premier multi-centered clinical research organization that conducts highly efficient clinical trials for the pharmaceutical industry. "Our Vision is to provide best practices in clinical research for the advancement of modern day medicine." Our staff has a combined experience of 15 years offering the "We Care" attitude to our patients and stakeholders. We are committed to serving our communities with best practices and innovating ideas that will positively impact the medical industry.

Welcome to Synergy Therapeutic Partners

"Today’s Standard Treatment was Yesterday’s Clinical Trial"

Synergy Therapeutic Partners (STP) provides efficient and high quality Phase II, III, IV, and over-the-counter clinical trials to the pharmaceutical industry.  Our staff is committed to the advancement of modern medicine by providing our clients with reliable and expeditious services.  We serve as the connecting force in meeting and exceeding expectations in patient recruitment and regulatory processing.

lg_test_tubes

STP is committed to making clinical trials accessible across diverse populations and providing patients with optimal care.  We ensure each patient is well-informed about the clinical research process. Please feel free to view the FAQs to learn more about participating in a clinical trial.   

FDA Drug Info Rounds
Drug Name Review
FDA Drug Info Rounds pharmacists discuss FDA's ...

Communicating Benefit and ...
FDA Drug Info Rounds pharmacists talk about the ...

Communicating Drug Safety ...
FDA Drug Info Rounds pharmacists discuss the ...

Drug Shortages Video
FDA Drug Info Rounds pharmacists discuss FDA's ...

Evamist Video
FDA Drug Info Rounds pharmacists discuss FDA's ...

Proton Pump Inhibitors (PPIs) ...
FDA Drug Info Rounds pharmacists discuss new ...

Long-Acting Beta-Agonists ...
Long-Acting Beta-Agonists (LABAs), a class of ...

Single-Ingredient Oral ...
FDA Drug Info Rounds pharmacists discuss the ...

NIH News Releases
NIH awards initial $46 ...
Projects lay the groundwork for visualizing the ...

NIH awards seven new vaccine ...
Scientists will use experimental and ...

Patient with exposure to ...
A patient with exposure to Ebola arrives at NIH ...

NIH to admit patient exposed ...
NIH expects to admit a patient who has been ...

NIH and FDA win top award for ...
The vaccine has a low production cost and does ...

NIH and VA address pain and ...
Research will focus on nondrug approaches.

NIH exceptional responders to ...
Study to investigate the molecular factors of ...

NIH announces network to ...
Partnership includes support from industry and ...

NIH funds next phase of ...
Scientists will integrate chips mimicking human ...

NIH awards $35 Million for ...
Three research teams receive funding over next ...

New supplemental awards apply ...
Investment sets the stage for a transformative ...

NIH awards aim to improve ...
Programs will improve scientists' understanding ...

New grants fund ...
NIH-funded projects aim at improving access, ...

NIH-convened panel recommends ...
Group produces first systematic evidence-informed ...

Eating habits, body fat ...
NIH study ties eating in response to food cues to ...

National Drug Facts Week 2015 ...
NIH observance links teens with scientific ...

NIAAA to conduct clinical ...
NIH researchers seek to expand treatment options.

NIH statement on ...
FASD Awareness Day is recognized each September.

Single animal to human ...
NIH-funded scientist uses latest genomic ...

NIH to Launch Human Safety ...
Trial is First in Series of Accelerated Safety ...

Scientists plug into a ...
NIH-funded study provides a neural explanation ...

NIH issues finalized policy ...
Policy's implementation is key to accelerating ...